BioSpace News Archive

Drug Development

Retrophin Announces Topline Results from Phase 3 FORT Study of Fosmetpantotenate in Patients with PKAN

Retrophin, Inc. announced that the Phase 3 FORT Study evaluating the safety and efficacy of fosmetpantotenate compared to placebo in patients with pantothenate kinase-associated neurodegeneration did not meet its primary endpoint and did not demonstrate a difference between treatment groups.

August 22, 2019
·
6 min read
Policy

Myriad Applauds the U.S. Preventive Services Task Force Recommendation on BRCA-Related Cancer Prevention

More Women May Benefit from Hereditary Cancer Risk Assessment and Genetic Testing

August 22, 2019
·
7 min read
Deals

Freeze and Thaw Systems Market Continues to Benefit from Biopharma Companies, Gains Remain Concentrated in ‘Disposable’ Systems

A report on the freeze & thaw systems market which considers the global industry analysis 2014 – 2018 and forecast 2019-2029 projects that, the freeze & thaw systems market is expected to reach ~ US$ 270 Mn by the end of 2019 in terms of value, and is forecasted to reach ~ US$ 550 Bn by the end of 2029.

August 22, 2019
·
3 min read
Job Trends

Denver Health Awarded $6.38 million Grant to Lead Effort to Prevent Dental Disease in Children

Study will evaluate outcomes from integrating oral health care with community health center services

August 22, 2019
·
2 min read
Job Trends

Denver Health to Reduce Unnecessary Antibiotic Use in Young Children with Ear Infections

Denver Health Foundation has been awarded a grant from The Gerber Foundation to fund a research project, the NO TEARS study, looking at ear infections, the most common childhood infection.

August 22, 2019
·
2 min read
Biotech Beach

Exploring the Next Global Developments in Health Innovation

CEOs Share Breakthroughs, Insights and Opportunities at “Think Asia, Think Hong Kong” Symposium

August 22, 2019
·
4 min read